Latest news
Loading news…
Adheron Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Berkeley, California, United States Founded 2003 1-10 employees For Profit
Adheron is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases.
Adheron Therapeutics was acquired by Roche in 2015 for $580M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 5
- IT spend
- $213K
Company Info
- Founded
- 2003
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 2
- HQ
- Berkeley, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Oct 7, 2015
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.5
- Trend (30d)
- -1.5
- Trend (90d)
- -0.2
Key People at Adheron Therapeutics
Founder
Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Adheron Therapeutics
Loading news…
FAQs about Adheron Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.